JLJae Won Lee

Jae Won Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jae Won Lee has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Stable Production and Functional Characterization of Recombinant Eel Follicle-Stimulating Hormone Analog Incorporating an eCG β-Subunit CTP and a Flexible GGSA Linker in CHO DG44 Cells

    by Munkhzaya Byambaragchaa, SongYong Kim, Hannah Kim, Jae Won Lee, Gisung You, Hyo Won Kim, Min Gyu Shin, Yonghyun Do, Kyong-Mi Won, Myung-Hum Park, et al.

    This study aimed to develop bioactive single-chain recombinant eel follicle-stimulating hormone (rec-eel FSH) analogs in Chinese hamster ovary DG44 (CHO DG44) cells. Our previous studies demonstrated that the O-linked glycosylated carboxyl-terminal peptide (CTP) of the equine chorionic gonadotropin (eCG) β-subunit enhances secretion in mammalian cells. Based on this observation, an FSH mutant (FSH-eM) was generated by inserting the eCG β-subunit CTP (amino acids 115–149) between the β- and α-subunits of wild-type single-chain eel FSH. Strep- and His-tags were fused to the C-terminus of the α-subunit for protein purification. The recombinant FSH-eM-Strep and FSH-eM-His proteins migrated as broad bands at 48–53 kDa. Sequential enzymatic digestion with PNGase F, O-glycosidase, and neuraminidase revealed the presence of both N- and O-linked glycans. To further investigate the potential of this approach as a candidate glycoengineering strategy, a flexible 15-amino acid linker [(GGSA)3GGG] was inserted between the β-subunit and the eCG β-subunit CTP, generating the FSH-GGSA-eM-Strep construct. Recombinant FSH-GGSA-eM-Strep was stably expressed in CHO DG44 cells and purified by Strep-Tactin XT affinity chromatography, demonstrating its suitability for large-scale production. Western blotting and silver staining showed an apparent molecular weight of 52–56 kDa. Following treatment with PNGase F, O-glycosidase, and neuraminidase, the molecular weight decreased to approximately 38, 42, and 42 kDa, respectively. cAMP accumulation assays demonstrated that rec-FSH-GGSA-eM-Strep stimulated eel FSHR-expressing cells in a dose-dependent manner. ERK1/2 phosphorylation reached a maximum at 5 min and rapidly declined thereafter. This response was markedly attenuated by treatment with the protein kinase A (PKA) inhibitor H89, suggesting that PKA activity contributes to ERK1/2 activation under the conditions tested. These findings suggest that this strategy may represent a promising approach for the production of biologically active recombinant eel FSH, with potential applications in reproductive biotechnology.